Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
“…based on 29 cases that progressed to MM or other LP diseases later in life, our study found midlife obesity to be a risk factor for progression among individuals diagnosed with MGUS.” HiContinue reading
“Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow. Multiple myeloma is the mostContinue reading
“Importantly, about 60% patients with MGUS progression met the criteria for multiple myeloma up to five years before their diagnosis…” Monoclonal Gammopathy of Undetermined SignificanceContinue reading
“Individuals with low-risk/intermediate-risk MGUS can convert to high-risk MGUS and progress to multiple myeloma within five years…” I think it makes sense that serum immune markers ofContinue reading
What Does It Mean for MGUS and HPV to be “Associated?” Actionable Non-Toxic Therapy is For the Pre-Myeloma Patient- The study linked and excerpted below cites a small study of MGUS patients,Continue reading
Peripheral Neuropathy (PN) as Symptom of Monoclonal Gammopathy of Undetermined Significance (MGUS) Monoclonal Gammmopathy of Undetermined Significance at a glance- click the illustration below: DiagnosticContinue reading